Clinical trials
Phase 3 Rectal Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 5 |
| Amgen | 2 |
| NCIC Clinical Trials Group | 2 |
| Sanofi | 2 |
| Canadian Cancer Trials Group | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 1 |
| International Atomic Energy Agency | 1 |
| Medical Research Council | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 24 |
| Colorectal Neoplasms | 19 |
| Colonic Neoplasms | 17 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Diseases | 1 |
| Digestive System Diseases | 1 |
| Digestive System Neoplasms | 1 |
| Febrile Neutropenia | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.